Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UCB Director's Dealing 2019

Jan 25, 2019

4017_mrq_2019-01-25_3b48ffc5-838d-492f-b97b-d352e49b7dd7.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Transparency notification BlackRock, Inc.

  • Notification referring to situation on 18 January 2019
  • Threshold crossed: 5%
  • Latest holding: 4,98 %

Brussels (Belgium), 25 January 2019 – 20:00 (CET) – regulated information

1. Summary of the notification

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received a transparency notification from BlackRock, Inc. (having its registered office at 55 East 52nd Street, New York, NY, 10055, U.S.A.), dated 21 January 2019.

BlackRock, Inc., has notified that, following a disposal of UCB shares with voting rights and an acquisition of equivalent financial instruments by its affiliates, its total holding in UCB SA/NV has decreased and has crossed downwards the 5% threshold on 18 January 2019.

On 18 January 2019, BlackRock, Inc. (taking into account the holding of its affiliates) owned 8 848 686 UCB shares with voting rights (versus 9 072 842 shares in its previous notification), representing 4.55% of the total number of shares issued by the company (194 505 658) (versus 4.66% in its previous notification), as well as 835 901 equivalent financial instruments (versus 720 194 in its previous notification) representing 0.43% of the total number of shares issued by the company (versus 0.37% in its previous notification).

2. Content of the notification

  • Reason for the notification: Acquisition or disposal of voting securities or voting rights.
  • Notification by: A parent undertaking or a controlling person.
  • Persons subject to the notification requirement:
Name Address (for legal entities)
BlackRock, Inc. 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock (Netherlands) B.V. Rembrandt Tower, 17th floor, Amstelplein, Amsterdam, Netherlands
BlackRock (Singapore) Limited 20 Anson Road #18-01, Singapore, 79912, Singapore
BlackRock Advisors (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Advisors, LLC 100 Bellevue Parkway, Wilmington, DE, 19809, U.S.A.
BlackRock Asset Management Canada Limited 161 Bay Street, Suite 2500, Toronto, Ontario, M5J 2S1, Canada
BlackRock Asset Management Deutschland AG Lenbachplatz 1 1st Floor, Munich, 80333-MN3, Germany
BlackRock Asset Management North Asia Limited 15/F, 16/F, 17/F Citibank Tower & 17/F ICBC Tower, 3 Garden Road, Central,
Hong Kong
BlackRock Financial Management, Inc. 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock Fund Advisors 400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock Institutional Trust Company, National
Association
400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock International Limited Exchange Place One, 1 Semple Street, Edinburgh, EH3 8BL, U.K.
BlackRock Investment Management (Australia)
Limited
Level 26, 101 Collins Street, Melbourne, VIC 3000, Australia
BlackRock Investment Management (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Investment Management, LLC 1 University Square Drive, Princeton, NJ, 8540, U.S.A.
BlackRock Japan Co., Ltd. 1-8-3 Marunouchi Chiyoda-ku, Trust Tower Main, Tokyo, 100-8217, Japan
  • Date on which the threshold is crossed: 18 January 2019.
  • Threshold crossed (in %): 5%
  • Denominator: 194 505 658.
  • Notified details:

UCB
News

A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the
securities
Linked to
securities
Not linked to the
securities
BlackRock, Inc. $\bf 0$ $\mathbf{0}$ 0.00%
BlackRock (Netherlands) B.V. 20,742 20,742 0.01%
BlackRock (Singapore) Limited 8,856 8,856 0.00%
BlackRock Advisors (UK) Limited 1,594,592 1,278,220 0.66%
BlackRock Advisors, LLC 184,540 182,784 0.09%
BlackRock Asset Management
Canada Limited
146,298 147,200 0.08%
BlackRock Asset Management
Deutschland AG
272.191 249,733 0.13%
BlackRock Asset Management North
Asia Limited
1,150 1,454 0.00%
BlackRock Capital Management, Inc. 32 $\mathbf{0}$ 0.00%
BlackRock Financial Management,
Inc.
155,852 165,565 0.09%
BlackRock Fund Advisors 2,539,565 2,538,485 1.31%
BlackRock Institutional Trust
Company, National Association
3,084,116 3, 137, 236 1.61%
BlackRock International Limited 43,104 46,306 0.02%
BlackRock Investment Management
(Australia) Limited
87,282 92,889 0.05%
BlackRock Investment Management
(UK) Limited
374,083 428,481 0.22%
BlackRock Investment Management,
LLC
374,277 368,850 0.19%
BlackRock Japan Co., Ltd. 186,162 181,885 0.09%
Subtotal 9,072,842 8,848,686 4.55%
TOTAL 8,848,686 0 4.55% 0.00%
B) Equivalent financial instruments After the transaction
Holders of equivalent
financial instruments
Type of financial instrument Expiration date Exercise period or
date
# of voting rights
that may be
acquired if the
instrument is
exercised
% of voting rights Settlement
BlackRock Advisors (UK) Limited Titres prêtés 198,751 0.10% physical
BlackRock Advisors (UK) Limited Contract de Difference 5,051 0.00% cash
BlackRock Advisors, LLC Contract de Difference 58,250 0.03% cash
BlackRock Financial Management,
Inc.
Contract de Difference 4,950 0.00% cash
BlackRock Institutional Trust
Company, National Association
Contract de Difference 376,252 0.19% cash
BlackRock Investment Management
(UK) Limited
Contract de Difference 21,216 0.01% cash
BlackRock Investment Management,
LLC
Contract de Difference 171,418 0.09% cash
BlackRock Investment Management,
LLC
Certificats 13 0.00%
TOTAL 835,901 0.43%
TOTAAL (A & B) # stemrechten % stemrechten
BEREKENEN 9,684,587 4.98%
  • Chain of controlled undertakings through which the holding is effectively held: Please see the full chain of control in the 'Chain of Control' tab.
  • Additional information:

The disclosure obligation arose due to total holdings for BlackRock, Inc. going below 5%.

3. Further information

This press release and the detailed transparency notification are available on UCB SA/NV's website via the following link.

An updated overview of the UCB SA/NV large shareholdings will be available on UCB SA/NV's website via the following link.

Investor Relations

Antje Witte, Investor Relations, UCB T +32 2 559 94 14, [email protected]

Isabelle Ghellynck, Investor Relations, UCB T +32 2 559 95 88, [email protected]

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7 500 people in approximately 40 countries, the company generated revenue of € 4.5 billion in 2017. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news